Schedule 13G ownership disclosure

XILIO THERAPEUTICS INC

Common Stock, par value $0.0001 per share · CUSIP: 98422T100

Event date: 2025-12-04

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Coastlands Capital LP

    Shares: 5,346,069.00 · Class: 9.99%

  • Coastlands Capital Partners LP

    Shares: 5,346,069.00 · Class: 9.99%

  • Coastlands Capital GP LLC

    Shares: 5,346,069.00 · Class: 9.99%

  • Coastlands Capital LLC

    Shares: 5,346,069.00 · Class: 9.99%

  • Matthew D. Perry

    Shares: 5,346,069.00 · Class: 9.99%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-25-120365
Form type
SCHEDULE 13G
Filer
Coastlands Capital LP
CIK
CIK 2068530
Filed
Dec 11, 2025
Reporting period
Dec 04, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub